Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Alexander Schmitz
AddedMar 31, 2024
UpdatedMay 31, 2026
Alexander Schmitz

Alexander Schmitz

Board Member, EndoStim

Crunchbase

Alexander Schmitz's Career

EndoStim
EndoStim

St. Louis, MO, US

Board Member· Board
Lumeon
Lumeon

Boston, MA, US

Board Member· Board
Nuvaira
Nuvaira

Minneapolis, MN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Alexander Schmitz's Career

EndoStim
EndoStim
Acquired$79.6M02009St. Louis, MO, US
Board Member· Board

Leadership at EndoStim

Rohan HoareRohan HoareBoard Member
Regina HoditsRegina HoditsBoard Member
Virender SharmaVirender SharmaBoard Member
Ralph G. DaceyRalph G. DaceyBoard Member
Doug FrenchDoug FrenchBoard Member
Lumeon
Lumeon
Series A$83.9M1132005Boston, MA, US
Board Member· Board

Leadership at Lumeon

Tom ZajacTom ZajacBoard Member
Robbie HughesRobbie HughesFounder
Nuvaira
Nuvaira
Series B$204M462008Minneapolis, MN, US
Board Member· Board

Leadership at Nuvaira

Steve DimmerSteve DimmerCo-Founder
Hank PlainHank PlainBoard Member
Kirk NielsenKirk NielsenBoard Member
Martin MayseMartin MayseCo-Founder
Tim HerbertTim HerbertBoard Member
Dennis WahrDennis WahrCEO

Similar to Nuvaira

NuvetaNuvetaPortola Valley, CA, USMedical Technologyest. 2009NuvetaPortola Valley, CA, US · est. 2009

US-based Nuveta Inc. provides innovative medical technology services.

Pre-Seed · $800k30
Aerwave MedicalAerwave MedicalNaples, FL, USMedical Devicesest. 2020Aerwave MedicalNaples, FL, US · est. 2020

Aerwave Medical: Pioneering non-drug COPD and asthma treatments since 2020, based in New York.

Seed · $8M7
NeVapNeVapSan Jose, CA, USMedical Devicesest. 2014NeVapSan Jose, CA, US · est. 2014

NeVap innovates cost-effective medical devices, like our FDA-approved tube, to combat Ventilator Associated Pneumonia.

Seed · $1M11
NirvaMedNirvaMedMinneapolis, MN, USMedical Devicesest. 2019NirvaMedMinneapolis, MN, US · est. 2019

NirvaMed: Innovating heart attack treatment with unique, non-invasive solutions for myocardial infarctions.

Series A · $5.1M5

Alexander Schmitz's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Alexander Schmitz

Dominique PitteloudDominique PitteloudCo-Founder · Climb VenturesHarpinder SinghHarpinder SinghBoard Member · StoryboxBernard VogelBernard VogelCo-Founder · Endeavour VisionWilliam SchmidtWilliam SchmidtBoard Member · MediprocityChristopher SchaepeChristopher SchaepeBoard Member · PersonalisJohn HoJohn HoBoard Member · Solchroma